Does Globus Medical, Inc. (NYSE:GMED) Have A Good P/E Ratio?

This article is for investors who would like to improve their understanding of price to earnings ratios (P/E ratios). To keep it practical, we’ll show how Globus Medical, Inc.’s (NYSE:GMED) P/E ratio could help you assess the value on offer. Globus Medical has a P/E ratio of 28.67, based on the last twelve months. That means that at current prices, buyers pay $28.67 for every $1 in trailing yearly profits.

See our latest analysis for Globus Medical

How Do You Calculate A P/E Ratio?

The formula for P/E is:

Price to Earnings Ratio = Share Price ÷ Earnings per Share (EPS)

Or for Globus Medical:

P/E of 28.67 = $43.76 ÷ $1.53 (Based on the trailing twelve months to March 2019.)

Is A High Price-to-Earnings Ratio Good?

The higher the P/E ratio, the higher the price tag of a business, relative to its trailing earnings. That isn’t necessarily good or bad, but a high P/E implies relatively high expectations of what a company can achieve in the future.

How Does Globus Medical’s P/E Ratio Compare To Its Peers?

The P/E ratio essentially measures market expectations of a company. If you look at the image below, you can see Globus Medical has a lower P/E than the average (41.6) in the medical equipment industry classification.

NYSE:GMED Price Estimation Relative to Market, July 26th 2019
NYSE:GMED Price Estimation Relative to Market, July 26th 2019

Its relatively low P/E ratio indicates that Globus Medical shareholders think it will struggle to do as well as other companies in its industry classification.

How Growth Rates Impact P/E Ratios

P/E ratios primarily reflect market expectations around earnings growth rates. When earnings grow, the ‘E’ increases, over time. That means even if the current P/E is high, it will reduce over time if the share price stays flat. Then, a lower P/E should attract more buyers, pushing the share price up.

Globus Medical increased earnings per share by an impressive 25% over the last twelve months. And earnings per share have improved by 15% annually, over the last five years. So one might expect an above average P/E ratio.

Don’t Forget: The P/E Does Not Account For Debt or Bank Deposits

The ‘Price’ in P/E reflects the market capitalization of the company. Thus, the metric does not reflect cash or debt held by the company. Theoretically, a business can improve its earnings (and produce a lower P/E in the future) by investing in growth. That means taking on debt (or spending its cash).

Spending on growth might be good or bad a few years later, but the point is that the P/E ratio does not account for the option (or lack thereof).

Globus Medical’s Balance Sheet

Since Globus Medical holds net cash of US$321m, it can spend on growth, justifying a higher P/E ratio than otherwise.

The Bottom Line On Globus Medical’s P/E Ratio

Globus Medical trades on a P/E ratio of 28.7, which is above its market average of 18. Its strong balance sheet gives the company plenty of resources for extra growth, and it has already proven it can grow. Therefore it seems reasonable that the market would have relatively high expectations of the company

Investors should be looking to buy stocks that the market is wrong about. As value investor Benjamin Graham famously said, ‘In the short run, the market is a voting machine but in the long run, it is a weighing machine.’ So this free visual report on analyst forecasts could hold the key to an excellent investment decision.

Of course you might be able to find a better stock than Globus Medical. So you may wish to see this free collection of other companies that have grown earnings strongly.

We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.

If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned. Thank you for reading.